Health
Moderna begins first late-stage US trial of Covid vaccine – Financial Times
Shares rise after 30,000 participants get their phase-three jabs
Moderna has given the first doses of its experimental Covid-19 vaccine to participants in what will be a 30,000-person trial, as the US moved into a new phase in the race to develop a vaccine by the start of next year.
The Boston-based biotech on Monday said it had begun the first phase-three study of a vaccine in the US, a large-scale trial that is usually the last before a new product is submitted for regulatory approval.
The company’s shares were up as much as 10.6 per cent before paring so…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General17 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General15 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General22 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says